Peroxidasin Inhibition by Phloroglucinol and Other Peroxidase Inhibitors
Human peroxidasin (PXDN) is a ubiquitous peroxidase enzyme expressed in most tissues in the body. PXDN represents an interesting therapeutic target for inhibition, as it plays a role in numerous pathologies, including cardiovascular disease, cancer and fibrosis. Like other peroxidases, PXDN generate...
Saved in:
Main Authors: | Martina Paumann-Page (Author), Christian Obinger (Author), Christine C. Winterbourn (Author), Paul G. Furtmüller (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of the Proprotein Convertase-Mediated Processing of Peroxidasin and Peroxidasin-like Protein
by: Hajnal A. Kovács, et al.
Published: (2021) -
Common Reactivity and Properties of Heme Peroxidases: A DFT Study of Their Origin
by: Daniel R. Ramos, et al.
Published: (2023) -
Pharmacophore-based discovery of 2-(phenylamino)aceto-hydrazides as potent eosinophil peroxidase (EPO) inhibitors
by: Daniela Schuster, et al.
Published: (2018) -
Phloroglucinol inhibits oxytocin-induced contraction in rat gastric circular muscle and uterine smooth muscle
by: Wenhui Yang, et al.
Published: (2023) -
Uric Acid Reacts with Peroxidasin, Decreases Collagen IV Crosslink, Impairs Human Endothelial Cell Migration and Adhesion
by: Bianca Dempsey, et al.
Published: (2022)